ThinkCyte, a Tokyo, Japan- and Redwood City, CA-based biotechnology company developing scientific instruments, raised raised an additional $15M in the extension round, bringing the total Series C to $32M.
The round was led by Japan Green Investment Corp. for Carbon Neutrality (JICN), KIRIN-GB Fund I L.P., and SMBC Venture Capital No. 7 Investment Limited Partnership. The company also secured a loan from Japan Finance Corporation. This latest round brings ThinkCyte’s total funding to $91m..
The company intends to use the funds to drive production and manufacturing scale-up as well as accelerate global commercial expansion.
Founded in 2016, ThinkCyte is a biotechnology company that develops scientific instruments based on integrated, multidisciplinary technologies to enable life science research, diagnostics, and therapeutic development. Its flagship product, VisionSort, is an AI-based, dual-mode fluorescence and morphometric cell sorting platform, which, since its launch in June 2023, has been adopted by major biopharmaceutical companies and academic institutions worldwide.
The company partners with global biopharmaceutical companies and academic research institutes to further drive research.
FinSMEs
02/09/2024